The Promise of Automated Insulin Delivery

Connecting these technologies will provide clear advantages to people living with diabetes, according to Dr. Kazemi.

"An AID system is considerably more convenient, as a person doesn't have to constantly check their glucose levels and calculate basal insulin dosages. Because the process is automatic and doesn't require constant attention, it saves them time and worry, not to mention it cares for the person even when they are asleep and unable to monitor their glucose levels or administer insulin.

"Clinical trials,² using a variety of automated insulin delivery systems in children and adults, have consistently demonstrated improved glycemic control, evidenced by reduction in A1C, increased sensor time in target range, reduced glycemic variability, and reduction in hypoglycemia," said Dr. Kazemi.

The AID system can also decrease or suspend insulin administration to manage low blood glucose or increase insulin to manage hyperglycemia, important aspects of long-term diabetes management.

Making Diabetes Care Easier Around the World

Connecting these technologies is the future of diabetes care and indispensable to our goal of making diabetes management as easy as possible. By helping people remove as many mental, emotional and time concerns as possible, we are focused on bringing connected technology to people everywhere.

We recently partnered with Ypsomed and CamDiab to integrate our FreeStyle Libre 3 with their technology in Germany, with additional European countries to be announced this year.

"We'll provide the iCGM technology, and we’ll partner with companies that deliver insulin," said Dr. Kazemi. "We have a number of partners that will allow us to team up with leading insulin pump companies across the world to develop integrated solutions that streamline and improve daily diabetes management for people on insulin therapy."

In the United States, the FDA recently cleared our Freestyle Libre 2 and FreeStyle Libre 3 iCGM systems for AID integration, expanding our vision of helping people spend less time thinking about their diabetes and more time living productive lives.

As the future of diabetes care management both expands exponentially and becomes increasingly clear, we remain focused on developing and enhancing technologies that connect us with other innovators and the people who will most benefit from our combined efforts.
 

NOTE: FreeStyle Libre 3 integration with automated insulin deliver system mylife™ Loop (pictured above) available in Germany.

References

¹ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.

² Berget C, Messer LH, Forlenza GP. A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr. 2019 Aug;32(3):194-204. doi: 10.2337/ds18-0091. PMID: 31462873; PMCID: PMC6695255.